WEF-Davos 2018: Gavi announces new private-sector partnerships

New partnerships announced by Gavi at WEF-Davos 2018 demonstrate the critical role of private sector expertise in helping developing countries increase immunisation coverage. Learn more about how and where the partnerships will make a difference.

Nexleaf's ColdTrace technology allows for remote monitoring and data gathering of vaccine fridge operation, and will be installed in over 4,000 immunisation sites and vaccination storage facilities across Tanzania. Credit: Gavi/2014/Karel Prinsloo.

TANZANIA

Who’s partnering with Gavi?

Tanzania Government, Elma Philanthropies, Nexleaf Analytics and John Snow Inc.

How will the partnership support immunisation?

By strengthening cold chain performance and data-analysis.

What is each partner’s role?

  • Elma Philanthropies will provide investment through their Vaccines and Immunization Foundation, which aims to increase coverage and vaccine introductions. This will be matched through the Gavi Matching Fund.
  • Nexleaf Analytics will provide technical support and training for ColdTrace, innovative technology which allows countries to monitor the temperature of vaccine fridges remotely. ColdTrace will be installed at over 4,000 immunisation sites and vaccination storage facilities in Tanzania.
  • Tanzania’s Government will lead on project planning and long-term sustainability.
  • John Snow Inc., will provide technical and managerial project support.

What can we expect from the partnership?

  • ColdTrace will move Tanzania closer to its long-term vision of cold chain data visibility for its entire health clinic network.
  • Access to real-time data on vaccine fridge performance and power availability will improve maintenance and functionality.
  • Training government officials on the interpretation of real-time data will guide decision-making. Tanzania’s data on the performance of critical vaccine cold chain equipment will be available to other Gavi-supported countries, informing their own planning and budgeting for vaccine delivery systems.

Health worker administers rotavirus vaccine drops at a health clinic in Punjab province, Pakistan. Credit: Gavi/2017/Asad Zaidi.

PAKISTAN

Who’s partnering with Gavi?

RB (formerly known as Reckitt Benckiser)

How will the partnership support immunisation?

Financial support will directly fund the introduction and scale-up of the rotavirus vaccination programme in Pakistan. The vaccine protects against rotavirus disease, the leading cause of deadly diarrhoea in children around the world.

What is the partner’s role?

  • RB will commit GBP 1 million (matched by the Gavi Matching Fund).
  • RB, whose household brands are sold in almost 200 countries, will work with Gavi to reduce childhood deaths from diarrhoea.

What can we expect from the partnership?

  • RB’s financial support will help increase rotavirus vaccine coverage in Pakistan.
  • Globally, the partnership will also contribute to Gavi’s immunisation coverage and equity goals and RB’s target of removing diarrhoea as a top-5 cause of infant mortality by 2020.

The "M-Vaccin Côte d'Ivoire" project will inform parents about the importance of vaccination by sending text and voice messages. Credit: Gavi/2016/Frédérique Tissandier.

COTE D’IVOIRE

Who’s partnering with Gavi?

Orange, Côte d’Ivoire Government

How will the partnership support immunisation?

  • Over the next five years, Orange will use mobile phones to help improve communication about immunisation with parents and communities in 29 Côte d’Ivoire districts with low vaccination coverage and high dropout rates.

What is each partner’s role?

  • The Côte d’Ivoire Government will support the programme through data provision and regional guidance.
  • Orange and Gavi will jointly invest US$ 5.47 million in the “M-Vaccin” project over a period of five years, with half the funding coming from the Gavi Matching Fund.

What can we expect from the partnership?

  • Parents will receive SMS text and voice messages in their local language about the importance of vaccination as well as reminders about upcoming immunisation sessions.
  • Health workers will be able to use Orange’s M-Vaccin app to record community vaccination data and create family-specific vaccine schedules.
  • Greater and more reliable vaccine data for every child as well as additional monitoring data for pregnant women and general child health.
  • A proven model that can be applied to other Gavi-supported countries and areas with low vaccine coverage.

"The Ministry of Health is working with partners like Gavi to keep those target populations better informed about the importance of vaccination."  

Dr Raymonde Goudou Coffie, Côte d' Ivoire Minister of Health and Public Hygiene


Immunisation session at Kampala health clinic, Uganda. Credit: Gavi/2014/Tormod Simensen.

UGANDA

Who’s partnering with Gavi?

Uganda Government, United Parcel Service (UPS) and Freight in Time (FIT)

How will the partnership support immunisation?

  • By addressing vaccine availability at the health facility level ('the last mile') in Uganda.

What is each partner’s role?

  • UPS will provide management oversight of their regional agent Freight-in-Time (FIT), capacity building and analysis on how to optimise the supply chain and improve personnel management.
  • As Gavi's first African supply chain partner, FIT will transport and track all vaccines shipments to 152 clinics in 3 districts, and will monitor the cold chain and vaccine storage.

What can we expect from the partnership?

  • Increased efficiency in vaccine delivery through performance management of personnel.
  • Enhanced supply chain visibility, with more accurate stock balances and less wastage.
  • Improved strategic and managerial skills due to capacity building of key personnel.
  • Potential supply chain redesign and optimisation.